Methylphenidate (MPH; Ritalin, Concerta, Metadate or Methylin) is a psychostimulant drug approved for treatment of attention-deficit hyperactivity disorder, Postural Orthostatic Tachycardia Syndrome, and narcolepsy. It may also be prescribed for off-label use in treatment-resistant cases of lethargy, depression, neural insult, obesity, and rarely other psychiatric disorders such as Obsessive-Compulsive Disorder. Methylphenidate belongs to the pip...
More
Methylphenidate (MPH; Ritalin, Concerta, Metadate or Methylin) is a psychostimulant drug approved for treatment of attention-deficit hyperactivity disorder, Postural Orthostatic Tachycardia Syndrome, and narcolepsy. It may also be prescribed for off-label use in treatment-resistant cases of lethargy, depression, neural insult, obesity, and rarely other psychiatric disorders such as Obsessive-Compulsive Disorder. Methylphenidate belongs to the piperidine class of compounds and increases the levels of dopamine and norepinephrine in the brain through reuptake inhibition of the monoamine transporters. MPH possesses structural similarities to amphetamine, and, though it is less potent, its pharmacological effects are even more closely related to those of cocaine yet without those addictive effects. MPH is most commonly known by the Novartis trademark name Ritalin, which is an instant-release racemic mixture, although a variety of formulations and generic brand names exist.
Methylphenidate...
Less
